Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06891183
NA

Percutaneous Thermal Ablation in Lung Tumors

Sponsor: Assiut University

View on ClinicalTrials.gov

Summary

Lung cancer has a high incidence globally, with Egypt having it as the third most common and most lethal cancer, affecting 16.9% of males and 3.8% of females. While surgery is the preferred treatment for stage 1 non-small cell lung cancer due to positive outcomes, it carries significant risks due to patient comorbidities. Non-invasive treatments like radio frequency ablation (RFA) and microwave ablation (MWA) are alternatives for those unable to undergo surgery. These techniques use energy to destroy tumor tissue with minimal invasiveness and can be guided by computed tomography to ensure accurate ablation.

Official title: Percutaneous Thermal Ablation in Treatment of Lung Cancer

Key Details

Gender

All

Age Range

Any - Any

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2023-05-01

Completion Date

2026-05-01

Last Updated

2025-03-24

Healthy Volunteers

No

Conditions

Interventions

RADIATION

Percutaneous thermal ablation of lung tumors

Percutaneous radiofrequency ablation

Locations (1)

Faculty of medicine

Asyut, Egypt